News

Investors Eye Bullish Trends in Celsius Holdings Options

Investors Eye Bullish Trends in Celsius Holdings Options

Investors Eye Bullish Trends in Celsius Holdings Options

There's a notable buzz among wealthy investors regarding Celsius Holdings (NASDAQ: CELH), and this activity is catching the attention of market observers. Recent analysis has uncovered interesting movements in the options market that suggest anticipation of significant changes for the company.

Today, various reports have highlighted a striking level of options activity regarding Celsius Holdings. The details unveil that a total of 13 distinct options activities were tracked, signaling an unusual surge in interest that investors should observe closely.

Current Investor Sentiments

Amidst these developments, insights into sentiment reveal a fairly even split among investors, with approximately 46% expressing bullish views while the remaining 46% lean bearish. It’s interesting to note that the options data showcases a preference for calls over puts, indicating that bullish bets are more prominent at this time.

Projecting Price Movements

When delving deeper into volume and open interest, it appears that major players are forecasting a price oscillation within the range of $20.0 to $30.0 for Celsius Holdings over the preceding quarter. This insight underscores the speculation and anticipation that investors are wagering on during this period.

Exploring Volume and Open Interest Insights

Investigating the volume and open interest of option contracts is an essential strategy for any astute investor. By examining these figures, one can gauge the liquidity surrounding Celsius Holdings's options at specific strike prices.

The data indicates substantial shifts in call and put activity, particularly for options tied to strike prices between $20.0 and $30.0 over the past 30 days. Such volatility is telling of the dynamics at play within this stock’s options trading realm.

Recent Options Trading Activity Snapshot

This heightened focus on options represents a chance for seasoned investors to engage smartly in the market. Below are some of the largest trades observed recently:

Noteworthy Options Trades

  • Symbol: CELH | Type: CALL | Trade Type: TRADE | Sentiment: BEARISH | Exp. Date: 04/17/25 | Ask: $3.4 | Bid: $2.71 | Price: $2.9 | Strike Price: $27.50 | Total Trade Price: $130.5K | Open Interest: 9.1K | Volume: 460
  • Symbol: CELH | Type: CALL | Trade Type: SWEEP | Sentiment: BULLISH | Exp. Date: 07/18/25 | Ask: $7.15 | Bid: $6.95 | Price: $7.07 | Strike Price: $25.00 | Total Trade Price: $63.6K | Open Interest: 1.8K | Volume: 34
  • Symbol: CELH | Type: CALL | Trade Type: TRADE | Sentiment: BULLISH | Exp. Date: 04/17/25 | Ask: $6.9 | Bid: $6.8 | Price: $6.9 | Strike Price: $22.50 | Total Trade Price: $51.0K | Open Interest: 2.0K | Volume: 92
  • Symbol: CELH | Type: CALL | Trade Type: TRADE | Sentiment: BEARISH | Exp. Date: 06/20/25 | Ask: $5.05 | Bid: $4.95 | Price: $4.98 | Strike Price: $27.50 | Total Trade Price: $49.8K | Open Interest: 3.5K | Volume: 216
  • Symbol: CELH | Type: CALL | Trade Type: TRADE | Sentiment: BEARISH | Exp. Date: 03/28/25 | Ask: $2.13 | Bid: $2.0 | Price: $2.0 | Strike Price: $29.00 | Total Trade Price: $48.0K | Open Interest: 546 | Volume: 250

Understanding Celsius Holdings

Celsius Holdings operates within the energy drink sector of the nonalcoholic beverage market, predominantly in North America. The brand promotes natural ingredients and methods designed to boost metabolism, which appeals to those with active lifestyles. Their product line features a variety of offerings, including Celsius Originals beverages, a line known as Celsius Essentials, and portable Celsius On-the-Go drink mixes.

The Current Market Landscape for Celsius Holdings

  • CELH's latest trading volume reached 3,943,773, with a notable rise of 4.16%, settling at $28.53.
  • Current RSI indicators suggest the stock may be nearing overbought conditions.
  • Next earnings report is projected for a future date.

Expert Analyst Ratings for Celsius Holdings

Recently, several analysts have evaluated Celsius Holdings, with a consensus target price set at $41.0. Notable rating movements include:

  • An analyst from B. Riley Securities downgraded their rating to Buy, with a target price of $49.
  • Stifel maintains their Buy rating, projecting a target price of $37.
  • A Roth MKM analyst also downgraded their rating to Buy, with a price target of $38.
  • Needham continues to hold a strong Buy rating with a target set at $40.

Trading options can be a high-risk, high-reward strategy. To navigate these waters effectively, traders often emphasize ongoing education and attentive analysis to market trends. Staying informed on the latest option activities for Celsius Holdings can offer valuable insights for potential opportunities.

Frequently Asked Questions

What is Celsius Holdings known for?

Celsius Holdings specializes in energy drinks that empower active lifestyles, with a portfolio comprising several varieties aimed at health-conscious consumers.

What do the recent options movements suggest?

The recent spike in options activity indicates significant interest among investors, which might foreshadow imminent changes in stock performance.

How do analysts view Celsius Holdings?

Market analysts present a generally positive outlook, with a consensus target price and several maintaining Buy ratings.

What should new investors consider?

New investors should monitor market trends, understand the implications of options trading, and consider the risks and rewards associated with investment in Celsius Holdings.

How can investors stay informed about Celsius?

Investors can track the latest news, analysis, and options trends for Celsius Holdings through financial news platforms tailored for real-time updates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading